Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04796792 · ClinicalTrials.gov registry record · NA
Ultrasound to Facilitate Stone Passage
A NA study of Urinary Calculi and Urinary Stone, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 3
- Study locations
NCT04796792: Recruiting NA study of Urinary Calculi and Urinary Stone, sponsored by University of Washington.
NCT04796792 is a NA study of Urinary Calculi and Urinary Stone that is actively recruiting participants, run by University of Washington. The registered enrollment target is 140 participants, above the 66-participant average among 3 other Urinary Calculi trials with a reported enrollment target (112% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04796792, a NA study of Urinary Calculi and Urinary Stone, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a prospective, open-label, multi-center study to test the clinical feasibility of facilitating stone passage by the combination of breaking and repositioning stones with ultrasound, without the need for anesthesia.
Primary Outcome
Incidence of return health care visits associated with the device or procedure.
Conditions Studied
Interventions
- DEVICE Burst Wave Lithotripsy (BWL) and Ultrasonic Propulsion (UP)
Study Locations (3)
Washington
- VA Puget Sound Health Care System - Seattle
- University of Washington - Seattle
Indiana
- Indiana University Health - North Hospital - Carmel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2028-10-31 |
| Phase | NA |
What NCT04796792 shows while recruiting
NCT04796792 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, above the 66-participant average among 3 other Urinary Calculi trials with a reported enrollment target (112% higher).
The record links to 2 conditions, with Urinary Calculi appearing as the primary indexed condition, and to 1 intervention - of which Burst Wave Lithotripsy (BWL) and Ultrasonic Propulsion (UP) is the first listed.
NCT04796792 reports a single indexed study location in Washington, Indiana.
Frequently Asked Questions
What is clinical trial NCT04796792 about?
NCT04796792 is a clinical study titled "Ultrasound to Facilitate Stone Passage". This is a prospective, open-label, multi-center study to test the clinical feasibility of facilitating stone passage by the combination of breaking and repositioning stones with ultrasound, without the need for anesthesia.
What is the current status of trial NCT04796792?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2023-04-01. Estimated completion is 2028-10-31.
What conditions does trial NCT04796792 study?
This clinical trial studies the following conditions: Urinary Calculi, Urinary Stone.
What interventions are being tested in trial NCT04796792?
The interventions under investigation include: Burst Wave Lithotripsy (BWL) and Ultrasonic Propulsion (UP) (DEVICE).
Who is sponsoring clinical trial NCT04796792?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04796792 being conducted?
This trial has 3 study locations across Indiana, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Calculi
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study
RECRUITING · NA
-
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
ACTIVE NOT RECRUITING · NA
-
Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urinary Tract-Located Stones
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI